ConductScience.org, home

Paper24459652

Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil.

Park HJ and 4 others. World J Mens Health, 2013. Cited by 58 papers, by iCite.

Cite this record

ConductScience Library. Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil. Papers, record 24459652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24459652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil.
PubMed
Journal
World J Mens Health
PubMed
Year
2013
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
2.86
iCite
Revised in PubMed
2021-10-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Park HJHyun Jun
2Won JEJi Eon Joanne
3Sorsaburu SSebastian
4Rivera PDPaul David
5Lee SWSeung Wook

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References75

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118281145A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Eur Urol2008https://conductscience.org/library/papers/18281145PubMed
222704110Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men.J Urol2012https://conductscience.org/library/papers/22704110PubMed
321284024Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action.Neurourol Urodyn2011https://conductscience.org/library/papers/21284024PubMed
416387575Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).Am J Cardiol2005https://conductscience.org/library/papers/16387575PubMed
521502967National-wide data on the treatment of BPH in Korea.Prostate Cancer Prostatic Dis2011https://conductscience.org/library/papers/21502967PubMed
612509363Prevalence of three lower urinary tract symptoms in men-a population-based study.Fam Pract2003https://conductscience.org/library/papers/12509363PubMed
711750246Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia.Urology2001https://conductscience.org/library/papers/11750246PubMed
821812935Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats.J Sex Med2011https://conductscience.org/library/papers/21812935PubMed
923596600Prevalence of Benign Prostatic Hyperplasia on Jeju Island: Analysis from a Cross-sectional Community-based Survey.World J Mens Health2012https://conductscience.org/library/papers/23596600PubMed
107718025Reduced smooth muscle cell regeneration in Yoshida (YOS) spontaneously hypercholesterolemic rats.Atherosclerosis1994https://conductscience.org/library/papers/7718025PubMed
1121871706
Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
Eur Urol2011https://conductscience.org/library/papers/21871706PubMed
1216613526BPH: epidemiology and comorbidities.Am J Manag Care2006https://conductscience.org/library/papers/16613526PubMed
1317138653Characterization and functional role of androgen-dependent PDE5 activity in the bladder.Endocrinology2007https://conductscience.org/library/papers/17138653PubMed
1418005205An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.BJU Int2008https://conductscience.org/library/papers/18005205PubMed
1522759598Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck.J Sex Med2012https://conductscience.org/library/papers/22759598PubMed
1611696815Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate.J Urol2001https://conductscience.org/library/papers/11696815PubMed
1712853851Chronic ischemia increases prostatic smooth muscle contraction in the rabbit.J Urol2003https://conductscience.org/library/papers/12853851PubMed
1821475707Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors.Curr Bladder Dysfunct Rep2010https://conductscience.org/library/papers/21475707PubMed
1915091043Does anticholinergic medication have a role for men with lower urinary tract symptoms/benign prostatic hyperplasia either alone or in combination with other agents?Curr Opin Urol2004https://conductscience.org/library/papers/15091043PubMed
2021420124Update on AUA guideline on the management of benign prostatic hyperplasia.J Urol2011https://conductscience.org/library/papers/21420124PubMed

See all 75 referencesDownload CSV of references

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
42621383Bladder multilithiasis across different clinical scenarios: Multimodality imaging findings, differential diagnosis, and complication assessment in 4 patients.Radiol Case Rep2026https://conductscience.org/library/papers/42621383PubMed
42488927Fucoidan from Undaria pinnatifida Improves Benign Prostatic Hyperplasia Symptoms in Men: A Randomized, Double-Blind, Placebo-Controlled Study.Res Rep Urol2026https://conductscience.org/library/papers/42488927PubMed
42075556The Role of the Aging Bladder in Lower Urinary Tract Symptoms: Pathophysiology and Therapeutic Implications in Patients with Benign Prostatic Hyperplasia.Medicina (Kaunas)2026https://conductscience.org/library/papers/42075556PubMed
42021565Rates and Predictors of Persistent LUTS Medication Use After Laser Enucleation of the Prostate.Low Urin Tract Symptoms2026https://conductscience.org/library/papers/42021565PubMed
41809799Phosphodiesterase inhibitors for the management of lower urinary tract symptoms in men without benign prostatic hyperplasia: a systematic review.Transl Androl Urol2026https://conductscience.org/library/papers/41809799PubMed
41726851Evaluation of the Transition from Holmium:YAG to Pulsed Thulium:YAG for Laser Endoscopic Enucleation of the Prostate and the Effect on Procedural Performance.Eur Urol Open Sci2026https://conductscience.org/library/papers/41726851PubMed
41608110Modern approaches to BPH management: expert insights and the latest evidence from the 2024 International Functional and Reconstructive Urology Update.Ther Adv Urol2026https://conductscience.org/library/papers/41608110PubMed
41472933Postoperative tadalafil for recovery of continence and voiding function after radical prostatectomy for prostate cancer: a single-center experience.Prostate Int2025https://conductscience.org/library/papers/41472933PubMed
41350372Predictors and predictive performance of immune-inflammation indices for symptom severity in benign prostatic hyperplasia.Sci Rep2025https://conductscience.org/library/papers/41350372PubMed
41304774Comprehensive Analytical Studies on the Solubility and Dissolution Rate Enhancement of Tadalafil with Type IV Lipid Formulations.Pharmaceutics2025https://conductscience.org/library/papers/41304774PubMed
41047361Comparative Trends in the Treatment of Male Lower Urinary Tract Symptoms in South Korea and the United States of America (USA) Based on Korean National Health Insurance Data.World J Mens Health2026https://conductscience.org/library/papers/41047361PubMed
40759594
Efficacy and Safety of Mirabegron and Tamsulosin Combination Therapy Compared to Tamsulosin Monotherapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Results of a Multicenter, Randomized, Double-Blind, Phase III Clinical Trial.
World J Mens Health2026https://conductscience.org/library/papers/40759594PubMed
39872316A comprehensive analysis of erectile dysfunction prevalence and the impact of prostate conditions on ED among US adults: evidence from NHANES 2001-2004.Front Endocrinol (Lausanne)2024https://conductscience.org/library/papers/39872316PubMed
39725984Prostatectomy outcomes for patients with benign prostatic hyperplasia and its associated factors in East and West Gojjam zones comprehensive specialized hospitals, Northwest Ethiopia.Eur J Med Res2024https://conductscience.org/library/papers/39725984PubMed
39649919Prevalence of bacteriuria and treatment outcomes in patients with symptomatic benign prostatic hyperplasia: a prospective observational study.Ann Med Surg (Lond)2024https://conductscience.org/library/papers/39649919PubMed
37745908Changes of resistance indices after medication in benign prostatic hyperplasia: a prospective study.Prostate Int2023https://conductscience.org/library/papers/37745908PubMed
37006221Evaluation of intermittent tamsulosin in treating symptomatic patients with benign prostatic hyperplasia.Urol Ann2023https://conductscience.org/library/papers/37006221PubMed
36792092The Need for Prospective Cohort Study of the Association between Lower Urinary Tract Symptoms and Cognitive Decline in Elderly Individuals.World J Mens Health2023https://conductscience.org/library/papers/36792092PubMed
36629062Quisqualis indica extract for men with lower urinary tract symptoms: A randomized, double-blind, placebo-controlled trial.Investig Clin Urol2023https://conductscience.org/library/papers/36629062PubMed
36086750Factors associated with quality of life in patients with benign prostatic hyperplasia, 2009-2016.Medicine (Baltimore)2022https://conductscience.org/library/papers/36086750PubMed

See all 35 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354NCBI Gene
PDE5A8654PubTator's text mininghttps://conductscience.org/library/genes/8654NCBI Gene
RHOA387PubTator's text mininghttps://conductscience.org/library/genes/387NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24459652

GET https://conductscience.org/api/papers/v1/24459652/references?page=2